|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
P���� |
|
Ƥ��,��Ӧ�� |
| ��������������� | |
|
��ܲ�� |
|
���� |
| PubMed | |
|
Article by |
|
Article by |
P��������Ӧ��Ƥ���������еĵ�λ
��ܲ��, ����
�㽭��ѧ������һҽԺƤ���� ���� 310006
��Ӧ��Ƥ����һ�ַ���������������Ƥ����,�����൱����,ǣ�浽�Ŵ����������ߡ�������һϵ������,��ȷ�з������������в�ʮ�����.���������������-�ڷ���-Ƥ�����ߵ�ϵͳѧ˵,��ͼͨ����һѧ˵������Ӧ��Ƥ�ķ�������.�־�һ�����������ʡ���P���ʽ�����Ӧ��Ƥ�����������Ƽ�������.
[2] Toyuda M,Makino T,Kagonra M,et al.Immunolocalization of substance P in human skin mast cells.Arch Deanatol Res,2000,292(8):418-421.
[3] Ho WZ,Lai JP,Zhu XH,et al.Human monoeytes and macrophages express substance P and neurokinin-1 receptor.J Immunol,1997,159(11):5654-5660.
[4] Giannetti A,Girolomeni G.Skin reactivity to neuropeptides in atopic dermatitis.Br J Deanatol,1989,121(6):681-688.
[5] Osflere KS,Cewen T,Rustin MH.Neuropeptides in the skin of patients with atopie dermatitis.Clin Exp Dermnatol,1995,20(6):462-467.
[6] Tobin D,Nabarro G,Baart de la Faille H,et al.Increased number of immunorenctive nerve fibers in atopic dermatitis.J Allergy Clin Immunol,1992,90(4 Pt1):613-622.
[7] Pincelli C,Fanfini F,Massimi P,et al.Nenropeptides in skin from patients with atepic dermatitis:an immunohistechemical study.Br J Deanatol,1990,122(6):745-750.
[8] Sugiura H,Omoto M,Hirota Y,et al.Density and fine stucture of peripheral nerves in various skin lesions of atopie dermatitis.Arch Dermatol Res,1997,289(3):125-131.
[9] Enserink M.Drug therapies for depression:from MAO inhibitors to substance P.Science,1999,284(5412):239.
[10] Toyoda M,Morohashi M.Morphological assessment of the effects of cyclesporin A on mast cell--nerve relationship in atepic dermatitis.Acta Dean Venereol,1998,78(5):321-325.
[11] Condemi JJ et al.AUergy and Immunology MKSAP.2 ud ed.United States of America:American College of Physicians,1997.96-97.
[12] Duffy D.Atopie disease dud immunologie response.Science,1997,276(5309):17.
[13] Kang H,Byun DG,Kim JW.Effects of substance P and vasoactive intestinal peptide on interferon-gamma and interleukin-4 production in severe atopic dermatitis.Ann Alhrgy.Asthma Immunol,2000,85(3):227-232.
[14] Lai JP,Douglas SD,Ho WZ.Human lymphocytes express substance P and its receptor.J Nenroimmunol,1998,86(1):80-86.
[15] Lotz M,Vanghan JH,Carson DA.Effect of neurpeptides on production of inflammatory cytokines by human monocytes.Science,1988,241(4870):1218-1221.
[16] Kincy-Cain T,Best KL.Substance P-induced IL-12 production by murine macrophages.J Immunol,1997,158(5):2334-2339.
[17] Lai JP,Douglas SD,Rappaport E,et al.Identification of a delta isoform of preprotaebykinin mRNA in human mononuclear phagocytes and lyrapho-cytes.J Neuroimmunol,1998,91(1-2):121-128.
[18] Lai JP,Deuglas SD,Zhao M,et al.Quantiflcatian of substance P mRNA in human rnononuelear phagocytes and lymphocytes using a mimicbased RT-PCR.J Immunol Methods,1999,230(1-2):149-157.
[19] Lai JP,Ho WZ,Zhan GX,et al.Substance P antaganist(CP96,345) inhibits HIV-1 replication in human mononuelonr phagocytes.Proc Natl Acad Sci U S A,2001,98(7):3970-3975.
[20] Carolan EJ,C.asale TB.Effects of neuropeptides on neutrephil migration through noncellar and endothelial barriers.J Allergy Clin Immunel,1993,92(4):589-598.
[21] Smith CH,Barker JN,Morris RW,et al.Neuropeptides induce rapid ex-pression of endothelial cell adhesion molectdes and elicit granulocytic infdtration in human skin.J Immunol,1993,151(6):3274-3282.
[22] Marriott I,Best KL.Expression of authentic substance P receptors in murine and human dendritic cells.J Neuroimmunol,2001,114(1-2):131-141.